Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.04K Buy
+154
New +$5.54K ﹤0.01% 1108
2026
Q1
Sell
-313
Closed -$12.7K 1584
2025
Q4
$12.7K Sell
313
-556
-64% -$24.2K ﹤0.01% 1279
2025
Q3
$40.9K Buy
869
+617
+245% +$32K 0.01% 953
2025
Q2
$13.1K Buy
252
+15
+6% +$823 ﹤0.01% 1288
2025
Q1
$14.3K Buy
237
+145
+158% +$9.35K ﹤0.01% 1198
2024
Q4
$6.3K Sell
92
-96
-51% -$6.69K ﹤0.01% 1324
2024
Q3
$13.5K Sell
188
-143
-43% -$10.1K ﹤0.01% 1209
2024
Q2
$22.9K Buy
+331
New +$24.1K 0.01% 1032

Other funds holding CNMD

Quarry LP's CNMD Position: Q2 2026 in Review

Quarry LP opened a new position in CONMED (CNMD) in Q2 2026: 154 shares worth $5.04K. The stake represents ﹤0.01% of the portfolio and ranks #1108 among its holdings. This is a return to the name: Quarry LP previously reported a position in CNMD as recently as Q4 2025.

Quarry LP first reported a position in CNMD in Q2 2024 and has held it in 8 quarters since. The position peaked at $40.9K in Q3 2025. 247 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Quarry LP held 154 shares of CONMED worth $5.04K as of Q2 2026.
  • CONMED was a new Quarry LP position in Q2 2026.
  • CONMED made up ﹤0.01% of Quarry LP's portfolio in Q2 2026, its #1108 holding.
  • Quarry LP first reported a position in CONMED in Q2 2024 and has held it in 8 quarters since.
  • Quarry LP's CONMED position peaked at $40.9K in Q3 2025.
  • 247 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.